Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Cardiac surgery · Beijing Anzhen Hospital · Beijing

Dr. Gan Huili甘辉立

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Gan Huili

Professional overview

Dr. Gan Huili is a Chief Physician and Professor at Beijing Anzhen Hospital, specializing in surgical treatment of cardiovascular diseases, with clinical focus on minimally invasive cardiac surgery, atrial fibrillation ablation, coronary artery bypass grafting, congenital heart disease, valvular heart disease, and pulmonary circulation disorders.

SpecialtyCardiac surgery
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentMinimally Invasive Cardiovascular Surgery Center
HospitalBeijing Anzhen Hospital
CityBeijing

Areas of focus

Atrial fibrillationUses minimally invasive, small-incision thoracic surgery for ablation of solitary atrial fibrillation; has deep expertise in radiofrequency ablation for atrial fibrillation.
Coronary artery diseasePerforms total arterial coronary artery bypass grafting using bilateral internal mammary arteries and radial artery, under off-pump, bloodless conditions.
Congenital heart diseaseHas extensive experience in surgical treatment of complex congenital heart disease, especially when combined with pulmonary arterial hypertension.
Heart valve diseasePerforms surgical treatment of valvular heart disease, including in cases complicated by pulmonary arterial hypertension or coronary artery disease.
Pulmonary arterial hypertensionFocuses on surgical treatment of chronic thromboembolic pulmonary arterial hypertension (CTEPH) and congenital heart disease-associated pulmonary arterial hypertension.
Pulmonary embolismSpecializes in surgical treatment of acute pulmonary embolism and chronic thromboembolic pulmonary arterial hypertension.

Background

  • 2005Senior visiting scholar at the Heart Center, University of Pennsylvania School of Medicine; Cleveland Clinic Foundation; Cardiac Center, Children's Hospital of Philadelphia; Thornton Hospital, University of California, San Diego; and UCLA Medical Center.
  • 2006Senior visiting scholar at the Heart Center, University of Pennsylvania School of Medicine; Cleveland Clinic Foundation; Cardiac Center, Children's Hospital of Philadelphia; Thornton Hospital, University of California, San Diego; and UCLA Medical Center.
  • 2009Senior visiting scholar at CryoLife Center, Atlanta, USA.
  • 2011Clinical research fellow in surgical treatment of chronic thromboembolic pulmonary hypertension (CTEPH) at Thornton Hospital, University of California, San Diego, and Papworth Hospital, University of Cambridge, UK.

Experience & recognition

  • Authored the first worldwide English-language monograph on pulmonary embolism and pulmonary thromboendarterectomy, published by Nova Science Publishers in 2011.
  • Edited two additional English-language monographs on pulmonary hypertension and percutaneous coronary intervention, published by Nova Science Publishers in 2012 and 2013.
  • Served as Associate Editor for the authoritative monograph 'Pulmonary Arterial Hypertension in Congenital Heart Disease: Eisenmenger’s Syndrome—A Global Perspective'.
  • First described and named the 'wall eclipsing sign' on pulmonary artery CT angiography to differentiate pulmonary artery sarcoma from pulmonary embolism.
  • Published over 30 SCI-indexed papers, including 4 in The Journal of Thoracic and Cardiovascular Surgery and 3 in PLoS One.
  • Performed over 4,000 cardiovascular surgical procedures.
  • Led or participated in national research projects including National Natural Science Foundation of China (NSFC) grants, Beijing Natural Science Foundation, Beijing Science and Technology Special Fund, and the National Eleventh-Five Year Science and Technology Support Program.

Professional roles

  • Member, Chinese Medical Association (CMA) Society for Thoracic and Cardiovascular Surgery
  • Member, Chinese Medical Doctor Association (CMDA) Society for Thoracic and Cardiovascular Surgery
  • Editorial Board Member, Microcirculation Journal
  • Honorary Editorial Board Member, Pragmatic and Observational Research
  • Peer reviewer for Journal of Thoracic and Cardiovascular Surgery
  • Peer reviewer for Cardiovascular Therapeutics
  • Peer reviewer for Vascular Health and Risk Management

Frequently asked questions

What does Dr. Gan Huili specialize in?

Surgical treatment of atrial fibrillation using minimally invasive ablation; total arterial, off-pump, bloodless coronary artery bypass grafting; complex congenital heart disease (especially with pulmonary arterial hypertension); valvular heart disease; acute pulmonary embolism; and chronic thromboembolic pulmonary arterial hypertension.

Which hospital and department is Dr. Gan Huili in?

Minimally Invasive Cardiovascular Surgery Center at Beijing Anzhen Hospital

Sources

Dr. Gan Huili has not reviewed this page.